Clinical Trials Directory

Trials / Sponsors / Momenta Pharmaceuticals, Inc.

Momenta Pharmaceuticals, Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
TerminatedAn Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to
Generalized Myasthenia Gravis
Phase 22019-08-06
CompletedA Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administ
Generalized Myasthenia Gravis
Phase 22019-04-10
TerminatedSafety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients
Immune Thrombocytopenic Purpura (ITP)
Phase 1 / Phase 22018-12-21
CompletedAssessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects
Healthy Volunteers
Phase 12016-10-01
CompletedAn Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)
Healthy Volunteers
Phase 12016-05-09
CompletedUsability of an AI for M923 in Subjects With Moderate to Severe RA
Rheumatoid Arthritis
Phase 32016-04-01
CompletedAssessment of Pharmacokinetics and Safety of M923 Administered Via Auto-injector or Prefilled Syringe, in Heal
Healthy
Phase 12016-01-01
CompletedPhase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis
Chronic Plaque Psoriasis, Psoriasis
Phase 32015-09-01
TerminatedM402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
Metastatic Pancreatic Cancer
Phase 1 / Phase 22012-05-01
CompletedEvaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
Coronary Artery Disease (CAD)
Phase 22007-09-01